Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/09/17 | 2,630 | 2,677 | 2,580 | 2,676 | +44 | +1.7% | 234,900 |
2020/09/16 | 2,591 | 2,655 | 2,557 | 2,632 | +91 | +3.6% | 315,500 |
2020/09/15 | 2,471 | 2,570 | 2,373 | 2,541 | +20 | +0.8% | 466,100 |
2020/09/14 | 2,570 | 2,684 | 2,517 | 2,521 | +9 | +0.4% | 521,800 |
2020/09/11 | 2,373 | 2,535 | 2,305 | 2,512 | +186 | +8% | 424,100 |
2020/09/10 | 2,341 | 2,355 | 2,287 | 2,326 | -4 | -0.2% | 175,500 |
2020/09/09 | 2,265 | 2,368 | 2,254 | 2,330 | +49 | +2.1% | 313,000 |
2020/09/08 | 2,296 | 2,311 | 2,185 | 2,281 | ±0 | ±0% | 192,100 |
2020/09/07 | 2,310 | 2,464 | 2,212 | 2,281 | -8 | -0.3% | 508,400 |
2020/09/04 | 2,136 | 2,386 | 2,113 | 2,289 | +88 | +4% | 509,000 |
2020/09/03 | 2,176 | 2,229 | 2,136 | 2,201 | +25 | +1.1% | 200,500 |
2020/09/02 | 2,103 | 2,186 | 2,095 | 2,176 | +76 | +3.6% | 202,400 |
2020/09/01 | 2,084 | 2,174 | 2,058 | 2,100 | -18 | -0.8% | 196,700 |
2020/08/31 | 2,037 | 2,168 | 2,021 | 2,118 | +121 | +6.1% | 256,800 |
2020/08/28 | 2,100 | 2,110 | 1,878 | 1,997 | -123 | -5.8% | 282,700 |
2020/08/27 | 2,156 | 2,169 | 2,024 | 2,120 | -38 | -1.8% | 224,300 |
2020/08/26 | 2,165 | 2,231 | 2,130 | 2,158 | +9 | +0.4% | 132,800 |
2020/08/25 | 2,157 | 2,211 | 2,082 | 2,149 | -12 | -0.6% | 231,600 |
2020/08/24 | 2,100 | 2,171 | 2,070 | 2,161 | +50 | +2.4% | 164,200 |
2020/08/21 | 1,980 | 2,192 | 1,980 | 2,111 | +171 | +8.8% | 508,100 |
2020/08/20 | 1,919 | 2,028 | 1,905 | 1,940 | +11 | +0.6% | 228,600 |
2020/08/19 | 1,932 | 1,943 | 1,879 | 1,929 | +2 | +0.1% | 98,400 |
2020/08/18 | 1,816 | 1,947 | 1,810 | 1,927 | +126 | +7% | 279,600 |
2020/08/17 | 1,901 | 1,909 | 1,782 | 1,801 | -139 | -7.2% | 272,300 |
2020/08/14 | 1,875 | 1,976 | 1,852 | 1,940 | +84 | +4.5% | 267,100 |
2020/08/13 | 1,830 | 1,875 | 1,796 | 1,856 | +46 | +2.5% | 129,400 |
2020/08/12 | 1,830 | 1,849 | 1,782 | 1,810 | -28 | -1.5% | 79,700 |
2020/08/11 | 1,770 | 1,840 | 1,744 | 1,838 | +77 | +4.4% | 92,100 |
2020/08/07 | 1,708 | 1,784 | 1,708 | 1,761 | +53 | +3.1% | 82,900 |
2020/08/06 | 1,847 | 1,847 | 1,703 | 1,708 | -107 | -5.9% | 161,600 |
2020/08/05 | 1,805 | 1,846 | 1,766 | 1,815 | +12 | +0.7% | 89,400 |
2020/08/04 | 1,735 | 1,827 | 1,730 | 1,803 | +86 | +5% | 120,600 |
2020/08/03 | 1,626 | 1,744 | 1,625 | 1,717 | +91 | +5.6% | 82,400 |
2020/07/31 | 1,678 | 1,735 | 1,616 | 1,626 | -61 | -3.6% | 119,100 |
2020/07/30 | 1,679 | 1,699 | 1,609 | 1,687 | +19 | +1.1% | 71,400 |
2020/07/29 | 1,648 | 1,692 | 1,615 | 1,668 | +42 | +2.6% | 101,700 |
2020/07/28 | 1,654 | 1,694 | 1,550 | 1,626 | -21 | -1.3% | 240,700 |
2020/07/27 | 1,757 | 1,760 | 1,641 | 1,647 | -124 | -7% | 142,100 |
2020/07/22 | 1,680 | 1,805 | 1,668 | 1,771 | +86 | +5.1% | 201,500 |
2020/07/21 | 1,643 | 1,705 | 1,633 | 1,685 | +25 | +1.5% | 116,900 |
2020/07/20 | 1,573 | 1,660 | 1,554 | 1,660 | +93 | +5.9% | 157,100 |
2020/07/17 | 1,756 | 1,764 | 1,563 | 1,567 | -193 | -11% | 377,900 |
2020/07/16 | 1,819 | 1,860 | 1,744 | 1,760 | -78 | -4.2% | 126,800 |
2020/07/15 | 1,800 | 1,865 | 1,765 | 1,838 | +56 | +3.1% | 155,400 |
2020/07/14 | 1,851 | 1,930 | 1,779 | 1,782 | -72 | -3.9% | 332,800 |
2020/07/13 | 2,183 | 2,200 | 1,853 | 1,854 | -298 | -13.8% | 944,900 |
2020/07/10 | 1,775 | 2,152 | 1,773 | 2,152 | +400 | +22.8% | 127,500 |
2020/07/09 | 1,895 | 1,901 | 1,707 | 1,752 | -172 | -8.9% | 386,000 |
2020/07/08 | 1,857 | 1,945 | 1,820 | 1,924 | +107 | +5.9% | 241,800 |
2020/07/07 | 1,987 | 2,018 | 1,765 | 1,817 | -215 | -10.6% | 911,300 |
1201~
1250
件表示中 / 1668件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 63,300円 | - | - | 0.00% | - | 25.90倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
ノイルイミューン | 17,400円 | -28.6% | - | 0.00% | - | 1.75倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
ティムス | 15,800円 | - | - | 0.00% | - | 2.57倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
日ケミファ | 158,300円 | +7.5% | -77.4% | 3.16% | 38.07倍 | 0.30倍 |
|
後発薬中堅、検査薬事業が第2の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
モダリス | 8,700円 | - | - | 0.00% | - | 2.12倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
市場注目の銘柄
チャート関連のコラム